Company Filing History:
2 out of 145 
1 out of 6 
1 out of 1 Years Active: 2006-2015
Title: Innovations of Markus Imhof
Introduction
Markus Imhof is a notable inventor based in Chexbres, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of expression vectors and chromatin insulators. With a total of four patents to his name, his work has advanced the understanding and application of genetic engineering.
Latest Patents
One of his latest patents is titled "Expression vectors comprising the mCMV IE2 promoter." This invention relates to an expression vector that includes the promoter of the mCMV-IE2 gene, or a functional expression-promoting fragment thereof, and/or an enhancer of the mCMV-IE2 gene, or a functional expression-enhancing fragment thereof. Importantly, the expression vector does not contain any complete gene of the mCMV. Another significant patent is "Minimal DNA sequence acting as a chromatin insulator and its use in protein expression." This invention involves expression vectors that comprise a DNA sequence of 146 base pairs capable of acting as a chromatin insulator. It also includes host cells containing such vectors, a method of producing a desired polypeptide using these vectors, and the use of the DNA sequence itself.
Career Highlights
Throughout his career, Markus Imhof has worked with prominent companies in the biotechnology sector, including Merck Serono S.A. and Selexis S.A. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in the field.
Collaborations
Markus has collaborated with esteemed colleagues such as Philippe Chatellard and Nicolas Mermod. These partnerships have fostered innovation and have been instrumental in advancing their shared goals in biotechnology.
Conclusion
Markus Imhof's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence advancements in genetic engineering and expression systems.